Sleep Apnea Diagnostic Systems Market Outlook (2023 to 2033)

The global sleep apnea diagnostic systems market has reached a valuation of US$ 4.81 billion in 2023, with a projected CAGR of 6.8% from 2023 to 2033. By 2033, the market is anticipated to reach US$ 9.27 billion.

Working in shifts and stressful work environments cause sleep apnea, and various technological advancements in sleep apnea diagnostics devices are driving the growth of the global market for sleep apnea diagnostic systems.

Sleep apnea diagnostic systems face challenges from high costs and limited awareness, yet untapped opportunities in developing economies hold promise.

Attribute Details
Sleep Apnea Diagnostic Systems Market Estimated Value (2023) US$ 4.81 billion
Sleep Apnea Diagnostic Systems Market Estimated Value (2033) US$ 9.27 billion
Sleep Apnea Diagnostic Systems Market Value CAGR (2023 to 2033) 6.8%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sleep Apnea Diagnostic Systems Market Historic Sales Compared to 2023 to 2033 Forecast Outlook

The sleep apnea diagnostic systems market is mainly driven by increasing cases of sleep disorders and lifestyle disorders such as cardiovascular diseases, diabetes, obesity, and depression.

As per the FMI’s analysis, the global sleep apnea diagnostic systems demand was anticipated to reach a valuation of US$ 3.42 billion with a CAGR of 5.7% from 2018 to 2022.

With the healthcare industry tapping into next-generation technologies while assisting the development of advanced oral sleep apnea diagnostic systems, the market is anticipated to gain momentum over the forecast period.

Burgeoning demand for advanced polysomnography (PSG) devices within hospitals and sleep centers encourage the adoption of PSG devices and sleep apnea diagnostic systems over the coming years.

Other trends that are propelling the growth are rising favorable government initiatives, private organizations’ increased investment, and the rising prevalence of cardiovascular diseases and diabetes across the globe.

Lack of awareness about sleep disorders and social stigma related to mental health issues and sleep disorders are likely to limit the growth of sleep apnea diagnostic systems market.

However, with the increasing penetration of advanced technology coupled with the rising cases of undiagnosed and untreated sleep apnea, the demand for sleep apnea diagnostic systems likely accelerates over the coming years.

Based on these aforementioned factors, the market has been forecasted to exhibit steady growth, registering a CAGR of over 6.8% during the forecast period.

How do the Technological Advancements Spur the Adoption of Polysomnography Devices?

  • Expansion of the healthcare industry and the growing prevalence of untreated sleep apnea are driving the adoption of polysomnography (PSG) devices.
  • Increased awareness of mental health issues like depression, sleep disorders, and anxiety is fueling the demand for advanced technological medical equipment.
  • Growing health consciousness among individuals is leading to a preference for at-home care settings and advanced medical wearable devices.
  • The rising cases of cardiovascular disease and obesity globally contribute to the increased risk of developing sleep apnea.
  • Wearable advanced sleep apnea diagnostic systems are gaining popularity as people prefer convenient and wearable solutions.
  • Healthcare professionals and scientists are actively involved in research and development activities to introduce advanced sleep apnea diagnostic devices.
  • The integration of artificial intelligence and data science in PSG devices is enhancing efficiency and providing real-time data, boosting the demand for sleep apnea diagnostic systems.
  • The increasing preference for oral sleep apnea devices is driving the sales of sleep apnea diagnostic systems worldwide.
  • The approval of innovative devices such as the eXciteOSA, a prescription tongue muscle stimulation device, by regulatory authorities further contributes to the growth of sleep apnea diagnostic systems market.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

How does the Existence of a Large Pool of Undiagnosed Sleep Apnea Patients Stimulate Market Growth?

  • Lack of awareness regarding sleep disorders and their consequences has led to a significant increase in lifestyle disorders globally.
  • Untreated sleep apnea cases are prevalent in developing economies like India and China, contributing to the expanding pool of sleep apnea patients and presenting opportunities for market players.
  • Governments and healthcare professionals are actively embracing polysomnography (PSG) devices for accurate evaluation and diagnosis of sleep disorders, driven by advancements in modern medicine and growing awareness among the population.
  • Individuals who are obese or overweight have a higher susceptibility to sleep disorders such as sleep apnea and insomnia, leading to increased adoption of sleep apnea diagnostic systems in hospitals and sleep centers.
  • This growing adoption of sleep apnea diagnostic systems in healthcare facilities is generating significant revenues for key players in the market.
  • The economic burden of untreated sleep apnea, including increased healthcare costs and reduced productivity, is driving governments and healthcare systems to invest in sleep disorder management programs, creating opportunities for market growth.
  • Collaboration between healthcare providers, research institutions, and industry players is promoting the development of innovative solutions, leading to improved diagnostics and treatment options.

This collaborative approach enhances market growth by addressing the needs of the undiagnosed sleep apnea patient population.

Comparative View of the Market

Sleep Apnea Diagnostic Systems Market:

Attributes Sleep Apnea Diagnostic Systems Market
CAGR (2023 to 2033) 6.8%
Market Value (2033) US$ 9.27 billion
Opportunity Integration of telemedicine and remote monitoring technologies, which enables patients to undergo sleep apnea testing and receive diagnosis and treatment recommendations from the comfort of their own homes, increasing convenience and accessibility.
Key Trends The adoption of portable and wearable devices for sleep apnea monitoring and this trend aligns with the growing demand for home-based and patient-centric healthcare solutions.

Sleep Apnea Devices Market:

Attributes Sleep Apnea Devices Market
CAGR (2023 to 2033) 9.5%
Market Value (2033) US$ 20.4 billion
Opportunity The development of novel products, such pressure-compensating sensors, is expected to exponentially accelerate market expansion.
Key Trends The sleep apnea device market trends have been boosted by the constantly expanding geriatric population who suffer from sleep apnea and other related health issues.

Sleep Apnea Implants Market:

Attributes Sleep Apnea Implants Market
CAGR (2023 to 2033) 13.8%
Market Value (2033) US$ 1.15 billion
Opportunity In China and India, sleep-related problems are a significant problem, which presents a chance for the top manufacturers to grow their operations there and take market share.
Key Trends Innovations in neurostimulation technology are a major trend that is currently influencing the market for sleep apnea implants.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Insights

How does the United States of America Sleep Apnea Diagnostic Systems Market Gain Traction?

Rising incidence of sleep disorders such as sleep apnea, sleep walking and others have improved the adoption of sleep apnea diagnostic systems across the United States of America.

As per Future Market Insights, the market in the United States of America is anticipated to be a highly lucrative market during the forecast period, with a value share of 48.0% in 2022.

As cases of cardiovascular diseases, diabetes, and other lifestyle disorders are surging, prevalence of sleep apnea is expected to soar simultaneously.

Due to the rising burden of various healthcare concerns, adoption of sleep apnea diagnostic systems has surged across the United States of America. Favorable government policies, and investments for the development of advanced diagnostic systems further the adoption over the coming years.

Why is the Demand Trajectory for Sleep Apnea Diagnostic Systems Consistently on the Rise in China?

According to FMI, the China market is expected to witness impressive growth rate of 7.4% from 2023 to 2033 due the technological advancements in the healthcare sector. Demand for PSG devices is expected to surge in China due to the rising cases of sleep apnea.

The incidence of diabetes, anxiety, depression, and other diseases is on the rise, which has raised the risk of sleep disorders in patients. Due to this, the adoption of advanced PSG devices for the diagnosis of sleep apnea has increased across healthcare facilities in China.

What is Supporting Sleep Apnea Diagnostic Systems Sales across India?

The sales of sleep apnea diagnostic systems in India are supported by several unique factors that are facilitating the country’s anticipated growth rate of 6.7% from 2023 to 2033.

The increasing awareness among the general population and healthcare professionals about sleep disorders and their consequences have led to a greater demand for diagnostic systems.

The expansion of healthcare infrastructure and the availability of advanced technology in urban areas have made sleep apnea diagnostic systems more accessible to patients across the country.

Market growth is also fostered by the growing focus on preventive healthcare and early diagnosis that has spurred the adoption of these systems, promoting sales in the Indian market.

The growing adoption of telemedicine and digital health platforms in India has played a significant role in supporting the sales of sleep apnea diagnostic systems.

Category-wise Insights

Why are Actigraphy Monitoring Devices Highly Sought-After?

Actigraphy monitoring devices are highly sought-after due to their non-invasive nature and ability to provide objective and long-term data on sleep and activity patterns.

These devices offer a convenient and comfortable way to gather accurate information without disrupting an individual's sleep routine.

The market demand for actigraphy monitoring devices is driven by the growing awareness and recognition of the importance of sleep health, fostering the sub-segments value share of 39.68% in 2022.

Sleep disorders have become a global health concern, leading to an increased need for reliable and efficient methods of assessing sleep patterns.

Actigraphy devices provide an objective assessment of sleep parameters, such as sleep duration and efficiency, which helps clinicians and researchers identify sleep disorders, evaluate treatment outcomes, and monitor sleep patterns over time.

Who is the Leading End-User for Sleep Apnea Diagnostic Systems?

The adoption of sleep apnea diagnostic systems is anticipated to remain the maximum at sleep centers and clinics during the forecast period. As per Future Market Insights, sleep centers and clinics segment is expected to account for over 38.93% of the global market share.

Due to the rising incidence of sleep apnea across the globe, patients prefer sleep centers and clinics as they’re equipped with all the analysis and diagnostic systems. However, a shift in preference towards home sleep testing (HST) devices is expected to present new growth opportunities from the at-home care setting segment over the coming years.

FMI projects rapid growth of the sleep apnea diagnostic systems market from hospitals, driven by the high adoption of these systems for in-lab testing. Furthermore, the sleep apnea diagnostic system is anticipated to witness impressive traction in home care settings.

How is the Competitive Landscape in the Sleep Apnea Diagnostic Systems Market

Prominent players operating in the sleep apnea diagnostic systems market are focusing on product innovation and introduction to increase their sales. As per FMI, Koninklijke Philips N.V. and ResMed Inc. are the leading players dominating the market.

Leading players continue to address the unmet needs in the market through inorganic strategies such as mergers and acquisitions.

Increasing research & development activities for the development of advanced sleep apnea diagnostic systems likely open up lucrative opportunities for market players.

Strategies by Players:

  • Product Innovation for enhanced sleep apnea diagnostic systems.
  • Strategic Partnerships to leverage expertise and expand market presence.
  • Market Expansion through new regions and targeted customer segments.
  • Effective Marketing to raise awareness about sleep apnea diagnosis.
  • Acquisitions and Mergers to strengthen product portfolio and competitive advantage.
  • Customer Support and Training for enhanced satisfaction and loyalty.

Developments in the Market:

  • In June 2021, Itamar Medical, Israeli sleep apnea company announced the expansion of WatchPAT, at-home sleep apnea diagnostic testing line capabilities. The WatchPAT system attaches to a user’s index finger, chest, and wrist to diagnos sleep apnea events of the patient.
  • In February 2021, GoPAPfree, a leading homecare provider of oral appliance therapy for obstructive sleep apnea announced the launch of their new product O2Vent Optima, a highly effective and more convenient alternative to CPAP therapy.
  • In November 2020, Sommetrics, a developing products and services company, announced the latest product for sleep apnea, aerSleep II, received approval from the United States of America Food & Drug Administration (FDA) for the device designation.

Key Players

  • Koninklijke Philips N.V.
  • Becton, Dickinson and Company
  • Braedon Medical Corporation
  • Advanced Brain Monitoring Inc.
  • SOMNOmedics GmbH
  • ResMed Inc.
  • BMC Medical Co. Ltd.
  • Natus Medical Incorporated
  • MGC Diagnostics Corporation
  • Cleveland Medical Devices Inc.
  • Others

Market by Category

By Product:

  • Polysomnography (PSG) Devices
    • Ambulatory PSG Monitoring Devices
    • Clinical PSG Monitoring Devices
    • Sleep Apnea Screening Device
  • Nasal Flow Sensors
  • Peripheral Capillary Oxygen Saturation (SPO2)
  • Actigraphy Monitoring Devices

By End-User Type:

  • Home Care Settings
  • Hospitals
  • Sleep Centers & Clinics

By Region:

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • Asia Pacific excluding Japan
  • Japan
  • Middle East and Africa (MEA)

Frequently Asked Questions

Why China Market is Witnessing Higher Growth?

Technological advancements in the healthcare sector are growing the demand in China.

What is the Predicted Size of the Market by 2033?

The market is likely to reach US$ 9.27 billion by 2033.

What is Driving the Market Growth?

The growing prevalence of untreated sleep apnea is driving the market growth.

How the Sleep Apnea Diagnostic Systems Market Developed in the Past?

The market captured 5.7 CAGR between 2018 and 2022.

Which End-use Industry is Expected to Holds Lucrative Opportunities?

The sleep centers and clinics sector is likely to hold high revenue potential.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033

        5.3.1. Polysomnography (PSG) Devices

            5.3.1.1. Ambulatory PSG Monitoring Devices

            5.3.1.2. Clinical PSG Monitoring Devices

            5.3.1.3. Sleep Apnea Screening Device

        5.3.2. Nasal Flow Sensors

        5.3.3. Peripheral Capillary Oxygen Saturation (SPO2)

        5.3.4. Actigraphy Monitoring Devices

    5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By End-User Type, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-User Type, 2023 to 2033

        6.3.1. Home Care Settings

        6.3.2. Hospitals

        6.3.3. Sleep Centers & Clinics

    6.4. Y-o-Y Growth Trend Analysis By End-User Type, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By End-User Type, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. The USA

            8.2.1.2. Canada

        8.2.2. By Product

        8.2.3. By End-User Type

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Product

        8.3.3. By End-User Type

    8.4. Key Takeaways

9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Product

        9.2.3. By End-User Type

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product

        9.3.3. By End-User Type

    9.4. Key Takeaways

10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. United Kingdom

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Product

        10.2.3. By End-User Type

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By End-User Type

    10.4. Key Takeaways

11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Product

        11.2.3. By End-User Type

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By End-User Type

    11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Product

        12.2.3. By End-User Type

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By End-User Type

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Product

        13.2.3. By End-User Type

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By End-User Type

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Product

        14.2.3. By End-User Type

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By End-User Type

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Product

            15.1.2.2. By End-User Type

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Product

            15.2.2.2. By End-User Type

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Product

            15.3.2.2. By End-User Type

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Product

            15.4.2.2. By End-User Type

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Product

            15.5.2.2. By End-User Type

    15.6. United Kingdom

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Product

            15.6.2.2. By End-User Type

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Product

            15.7.2.2. By End-User Type

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Product

            15.8.2.2. By End-User Type

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Product

            15.9.2.2. By End-User Type

    15.10. Poland

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Product

            15.10.2.2. By End-User Type

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Product

            15.11.2.2. By End-User Type

    15.12. Czech Republic

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Product

            15.12.2.2. By End-User Type

    15.13. Romania

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Product

            15.13.2.2. By End-User Type

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Product

            15.14.2.2. By End-User Type

    15.15. Bangladesh

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Product

            15.15.2.2. By End-User Type

    15.16. Australia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Product

            15.16.2.2. By End-User Type

    15.17. New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Product

            15.17.2.2. By End-User Type

    15.18. China

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Product

            15.18.2.2. By End-User Type

    15.19. Japan

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Product

            15.19.2.2. By End-User Type

    15.20. South Korea

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Product

            15.20.2.2. By End-User Type

    15.21. GCC Countries

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2022

            15.21.2.1. By Product

            15.21.2.2. By End-User Type

    15.22. South Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2022

            15.22.2.1. By Product

            15.22.2.2. By End-User Type

    15.23. Israel

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2022

            15.23.2.1. By Product

            15.23.2.2. By End-User Type

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Product

        16.3.3. By End-User Type

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Koninklijke Philips N.V.

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Becton, Dickinson and Company

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Braedon Medical Corporation

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. Advanced Brain Monitoring Inc.

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. SOMNOmedics GmbH

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. ResMed Inc.

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. BMC Medical Co. Ltd.

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. Natus Medical Incorporated

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. MGC Diagnostics Corporation

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Cleveland Medical Devices Inc.

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Recommendations

Healthcare

Sleep Apnea Implants Market

May 2021

REP-GB-8698

May 2023

229 pages

Healthcare

Sleep Apnea Devices Market

March 2022

REP-GB-14383

February 2023

322 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Sleep Apnea Diagnostic Systems Market